LOAN logo

Manhattan Bridge Capital, Inc.

NASDAQ: LOAN

Manhattan Bridge Capital: A 10% Dividend Our Model Won’t Buy

Finrys ResearchJuly 13, 202610 min read

Finrys snapshot · FY2025

OVERVALUED

$4.30

Price

$3.77

Fair value

9.8×

P/E

10.2%

Dividend yield

Manhattan Bridge Capital is a $49.2 million company that lends money to house-flippers in New York. It pays a 10.2% dividend, trades on 9.8× earnings, passes seven of our eight health pillars — and in 1,340+ loans since 2007 it has never once foreclosed on a property. It also earns a verdict of Overvalued from our model and a 1-out-of-5 predictability score. That contradiction is the whole story — and resolving it takes you somewhere no ratio on the report can: into a single footnote of the 10-K.

Open the live LOAN report on Finrys →

The business

How a hard-money lender makes money

Forget the name — this is not a bank and it owns no buildings. It is a bridge lender: a house-flipper finds a property, needs cash in days rather than the weeks a mortgage takes, and pays a high rate for the speed. Manhattan Bridge writes the cheque, takes the house as collateral, collects interest for about a year, and gets its money back when the flipper sells or refinances. Three things make that work.

Where the yield comes from

The loan

Short-term first-mortgage loans to house-flippers and small developers: a fixed 11.12% average rate, interest-only, typically a one-year term, plus a 0–2% origination fee. Speed is the product — borrowers pay up because a bank cannot close in days.

Where the safety comes from

The collateral

A first lien at no more than 75% loan-to-value, plus a personal guarantee from the borrower’s principals. No single loan may exceed the lower of 9.9% of the book or $4 million — so one bad deal cannot take the company down.

Where the profit comes from

The funding

They borrow at ~6.7–7.3% on two bank lines and lend at ~11.12%, keeping the spread. Only $17.6M is drawn against $43.1M of equity — leverage of just 0.45×, which is unusually tame for a lender.

As a REIT, the company pays almost no corporate tax — on condition that it hands at least 90% of its taxable income to shareholders. That is why the dividend is the product here. You are not buying growth; you are buying a slice of an interest-rate spread, paid out to you four times a year.

Quality

Profitable, disciplined — and utterly unpredictable

The profitability is real: about 59 cents of every revenue dollar reaches net income, on a 11.6% return on capital and a 12% return on equity. Those are honest numbers for a lender running at just 0.45× leverage. But look at the fourth card.

11.6%

ROIC (5y)

12%

Return on equity

59%

Net margin

1/5 ★

Predictability

Finrys health check

7 of 8 pillars passed

Every stock on Finrys runs through a Graham-inspired 8-point quality checklist before any valuation. Manhattan Bridge passes seven — cheap on earnings, cheap on cash flow, high returns, no dilution, almost no debt. It fails exactly one, and it fails it by a whisker: profit is up 15.6% over five years against a 20% bar.

  • TTM P/E

    You’re not overpaying — the price is sensible relative to current earnings.

    9.6×

    TTM P/E < 22.5×

  • Growing Profits

    Bottom-line profit is higher than it was five years ago.

    +15.6%

    5Y net income growth ≥ 20%

  • High Return on Capital

    The business earns a strong return on the capital invested in it.

    +11.6%

    5Y ROIC > 9%

  • Growing Sales

    The top line is growing — the company sells more than it used to.

    +27.3%

    5Y revenue growth ≥ 20%

  • Shareholder Friendly

    Share count is shrinking, so each share owns more of the company.

    −0.5%

    5Y share count shrinking (Δ < 0)

  • Manageable Debt

    Long-term debt could be cleared with just a few years of cash flow.

    0.0×

    Long-term debt / 5Y FCF < 5×

  • Growing Cash Flow

    The actual cash the business throws off keeps rising.

    +7.4%

    5Y cash-flow growth > 0

  • Good Cash Generation relative to Price

    You pay a fair price for every dollar of cash the company generates.

    10.0×

    TTM P/FCF < 22.5×

Five-year growth

Finrys data (total growth over the health-check window).

Notice the shape: sales grew, profit grew less, and cash flow barely moved. The engine still runs — it is just losing power. And in 2025 it went into reverse: revenue -10.6% to $8.67M, net income -8.6% to $5.11M, and the loan book shrank from $65.97M to $60.67M.

The catch

The number that isn’t on the report

Here is the single most important thing to understand before you trust any of the ratios above. A lender’s risk does not live in its margins — it lives in its loan book. And Manhattan Bridge carries an allowance for credit losses of exactly zero. Not a small one. Zero. Management’s justification is a genuinely remarkable record: 1,340+ loans since 2007, not one completed foreclosure. On that history, zero is arguably honest.

But look at how the book stays clean. Of the $60.67M outstanding at year-end, about $39.81M consists of loans that are already past their original due date — including one that was due in 2016 — and are still counted as performing because, in the 10-K’s own words, the borrowers “have either signed an extension agreement or are in the process of signing” one.

The loan book by original due date

FY2025 10-K. Everything right of the first bar has been rolled past its own maturity — $39.81M of the $60.67M book, with $19.52M of it rolling for more than a year.

The dividend

A 10% yield that just got smaller

This is what you are actually buying. The quarterly dividend is $0.11 a share — $0.44 a year, a 10.2% yield at $4.30. That is a genuinely high income stream, and it is paid in cash, quarterly, by a company with no meaningful debt.

But it was $0.115 until February 2026, when the board cut it. That is a small cut, and small cuts are easy to wave away — except that this one is the arithmetic catching up. For FY2025 the company declared roughly 103% of its reported profit as dividends. When the loan book shrinks, interest income shrinks with it, and a REIT paying out everything it earns has only one lever left.

10.2%

Dividend yield

paid quarterly

$0.11

Quarterly dividend

cut from $0.115 in Feb 2026

103%

Payout ratio

of FY2025 profit

Valuation

Why a 9.8× P/E can still be “overvalued”

Our model puts fair value at $3.77 — below the $4.30 price — and calls the stock Overvalued. On a 9.8× P/E, that sounds absurd. It isn’t, and the reason is worth understanding, because it applies to every lender you will ever screen.

OVERVALUED

$3.77

Finrys fair value

$2.64

Buy below (30% MoS)

$2.51

Phil Town sticker

$4.31

10-Cap (deep value)

Valuation anchors vs. price

Finrys outputs across four methods. Dashed line = price ($4.30). Three of the four sit below it.

For the Finrys investor

What this means for you

Manhattan Bridge is the mirror image of the wide-moat names we usually write about. Adobe is a great business at a questionable price. This is a well-run business at a fair price — and the question is not whether it is cheap, but whether the income is durable.

The other side

Risks to keep in view

A zero credit-loss allowance leaves no cushion

The company carries no allowance for credit losses at all — not a small one, zero. That is defensible given a spotless history, but it means the first real loss lands directly in net income with nothing to absorb it. A single maximum-size $4M loan going bad would wipe out roughly three-quarters of a year’s profit.

Two-thirds of the book is past its original due date

Loans originally due in 2016, 2020, 2022, 2023, 2024 and 2025 — about $39.8M of the $60.7M book — are still outstanding, carried as performing because the borrower "has signed, or is in the process of signing" an extension. The auditor flagged the zero allowance as a Critical Audit Matter for exactly this reason. Extensions can be ordinary bridge-lending practice; they can also be how a problem loan stays invisible.

The book is shrinking, and the dividend followed

Revenue fell 10.6% and the portfolio shrank from $66.0M to $60.7M — despite $22.6M of undrawn bank capacity sitting idle. In February 2026 the quarterly dividend was cut from $0.115 to $0.11. Whether that shrinkage is discipline (refusing bad loans) or lost competitiveness is the single most important open question on this stock.

93% of the collateral is in one metro area

Nearly every loan is secured by property in the New York metro area. This is not a diversified lender — it is a leveraged bet on one regional property market, and it has never been tested through a genuine NY price decline with a book this heavily extended.

Micro-cap illiquidity

At a ~$49.2M market cap and roughly 40,000 shares of daily volume, this is a stock you can walk into far more easily than you can walk out of. Position sizing matters more than usual.

Bottom line

So, is Manhattan Bridge a buy?

On business quality, it is far better than its size suggests: 11.6% returns on capital, 0.45× leverage, no dilution, a founder with 22.8% of the shares, and a credit record — zero foreclosures in 1,340+ loans — that most lenders would kill for. On price, our model says you are paying about what it is worth: fair value $3.77 against a $4.30 price, with the 10-Cap landing almost exactly on today’s quote. What you get for that price is a 10.2% yield from a shrinking loan book, backed by a zero credit-loss allowance whose credibility rests on extensions the auditor has formally flagged. If the extensions are what management says they are, this is a solid income holding that will never make you rich. If they aren’t, the first loss lands straight in the earnings — and there is nothing set aside to catch it. Track it on Finrys, decide which of those you believe, and size the position accordingly.

This article is for educational purposes only and is not investment advice. Finrys is not a financial adviser (always do your own research). Ratios, pillars and valuation anchors are a static snapshot of Finrys data (FY2025 fundamentals); loan-book, credit-quality and dividend figures come from the company’s FY2025 Form 10-K, filed 27 March 2026. See the live report for current numbers. Read our full disclaimer.